Anaplastic transformation of thyroid cancer: Review of clinical, pathologic, and molecular evidence provides new insights into disease biology and future therapy
- 21 July 2003
- journal article
- review article
- Published by Wiley in Head & Neck
- Vol. 25 (8) , 662-670
- https://doi.org/10.1002/hed.10277
Abstract
Background.: Anaplastic thyroid cancer ranks among the most lethal of all human malignancies. Its rarity and rapidly fatal course have made it a difficult cancer to both study and treat. Unfortunately, there has been little progress in the management and control of this malignancy. Anaplastic transformation, or the intratumoral evolution of anaplastic carcinoma from pre‐existing differentiated thyroid cancer, has become a well‐accepted process, despite a limited understanding of its underlying mechanisms.Methods.: It is through review of the literature that an understanding of the aggressive disease biology can be developed. The aim of this review is to evaluate the relevant clinical, pathologic, and molecular studies to develop an insight into the mechanisms that underlie the intratumoral molecular evolution of anaplastic thyroid carcinoma.Results/Conclusion.: It is based on an understanding of this process that effective treatments for this aggressive malignancy are currently being developed. © 2003 Wiley Periodicals, Inc. Head Neck 25: 662–670, 2003Keywords
This publication has 78 references indexed in Scilit:
- Construction of Gene Therapy Vectors Targeting Thyroid Cells: Enhancement of Activity and Specificity with Histone Deacetylase Inhibitors and Agents Modulating the Cyclic Adenosine 3',5'-Monophosphate Pathway and Demonstration of Activity in Follicular and Anaplastic Thyroid Carcinoma CellsJournal of Clinical Endocrinology & Metabolism, 2001
- Identifying Differentially Expressed Genes Associated with Metastasis of Follicular Thyroid Cancer by cDNA Expression ArrayThyroid®, 2001
- Adenovirus-Mediated Tumor Suppressor p53 Gene Therapy for Anaplastic Thyroid Carcinoma in Vitro and in VivoJournal of Clinical Endocrinology & Metabolism, 2000
- Loss of p53 Promotes Anaplasia and Local Invasion in ret/PTC1-Induced Thyroid CarcinomasThe American Journal of Pathology, 2000
- DNA Copy Number Changes in Thyroid CarcinomaThe American Journal of Pathology, 1999
- Mutations of p53 in Thyroid Carcinoma with an Insular ComponentThyroid®, 1999
- Alteration of tumorigenicity in undifferentiated thyroid carcinoma cells by introduction of normal chromosome 11Journal of Surgical Oncology, 1994
- p53 mutations in all stages of thyroid carcinomasJournal of Clinical Endocrinology & Metabolism, 1993
- Detection of theH-RAS oncogene in human thyroid anaplastic carcinomasCellular and Molecular Life Sciences, 1989
- Thyroid carcinoma—Biologic behavior and mortality:Postmortem findings in 42 cases, including 27 in which the disease was fatalCancer, 1966